The CXCR3 Ligands CXCL9, CXCL10 and CXCL11 Up-regulate IL-13Rα2 in NIH-3T3 Fibroblasts

被引：0
|
作者：
Worrell, J. C. [1 ]
Lumsden, R. V. [1 ]
Barnes, J. C. [1 ]
Walsh, S. M. [2 ,3 ]
Boylan, D. A. [1 ]
Kane, R. [1 ]
Keane, M. P. [2 ,3 ]
机构：
[1] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin 4, Ireland
[2] St Vincents Univ Hosp, Dept Resp Med, Dublin 4, Ireland
[3] Univ Coll Dublin, UCD Conway Inst, Sch Med & Med Sci, Dublin 4, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2013年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S466 / S466
页数：1
相关论文
共 50 条
  • [1] CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration
    Koper, Olga M.
    Kaminska, Joanna
    Sawicki, Karol
    Kemona, Halina
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (06): : 849 - 856
  • [2] Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function
    Colvin, RA
    Campanella, GSV
    Sun, JT
    Luster, AD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (29) : 30219 - 30227
  • [3] CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11
    Xanthou, G
    Duchesnes, CE
    Williams, TJ
    Pease, JE
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (08) : 2241 - 2250
  • [4] Comparative Expression of CXCR3 Chemokine Receptor and Their Ligands (CXCL9, CXCL10 and CXCL11) in Cutaneous Melanoma Progression
    Pellin-Carcelen, A.
    Ramos, D.
    Martin, J.
    Jordc, E.
    Pellin, A.
    Monteagudo, C.
    MODERN PATHOLOGY, 2009, 22 : 108A - 108A
  • [5] Comparative Expression of CXCR3 Chemokine Receptor and Their Ligands (CXCL9, CXCL10 and CXCL11) in Cutaneous Melanoma Progression
    Pellin-Carcelen, A.
    Ramos, D.
    Martin, J.
    Jorda, E.
    Pellin, A.
    Monteagudo, C.
    LABORATORY INVESTIGATION, 2009, 89 : 108A - 108A
  • [6] Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum
    Mueller, M.
    Carter, S.
    Hofer, M. J.
    Campbell, I. L.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2010, 36 (05) : 368 - 387
  • [7] CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
    Tokunaga, Ryuma
    Zhang, Wu
    Naseem, Madiha
    Puccini, Alberto
    Berger, Martin D.
    Soni, Shivani
    McSkane, Michelle
    Baba, Hideo
    Lenz, Heinz-Josef
    CANCER TREATMENT REVIEWS, 2018, 63 : 40 - 47
  • [8] Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation
    Flier, J
    Boorsma, DM
    van Beek, PJ
    Nieboer, C
    Stoof, TJ
    Willemze, R
    Tensen, CP
    JOURNAL OF PATHOLOGY, 2001, 194 (04): : 398 - 405
  • [9] The role of CXCR3 and its ligands CXCL10 and CXCL11 in the pathogenesis of celiac disease
    Haghbin, Mahrokh
    Rostami-Nejad, Mohammad
    Forouzesh, Flora
    Sadeghi, Amir
    Rostami, Kamran
    Aghamohammadi, Elham
    Asadzadeh-Aghdaei, Hamid
    Masotti, Andrea
    Zali, Mohammad Reza
    MEDICINE, 2019, 98 (25) : e15949
  • [10] The Serum Level of CXCL9, CXCL10, and CXCL11 and the Expression of CXCR3 of Peripheral Blood Mononuclear Cells in Brucellosis Patients
    Farzaneh Hassanshahi
    Mojgan Noroozi Karimabad
    Elahe Miranzadeh
    Gholamhossein Hassanshahi
    Seyedeh Atekeh Torabizadeh
    Ali Jebali
    Current Microbiology, 2023, 80
12345